Literature DB >> 25239202

QSAR analysis on tacrine-related acetylcholinesterase inhibitors.

Kai Y Wong, Andrew G Mercader, Laura M Saavedra, Bahareh Honarparvar1, Gustavo P Romanelli, Pablo R Duchowicz.   

Abstract

BACKGROUND: The evaluation of the clinical effects of Tacrine has shown efficacy in delaying the deterioration of the symptoms of Alzheimer's disease, while confirming the adverse events consisting mainly in the elevated liver transaminase levels. The study of tacrine analogs presents a continuous interest, and for this reason we establish Quantitative Structure-Activity Relationships on their Acetylcholinesterase inhibitory activity.
RESULTS: Ten groups of new developed Tacrine-related inhibitors are explored, which have been experimentally measured in different biochemical conditions and AChE sources. The number of included descriptors in the structure-activity relationship is characterized by 'Rule of Thumb'. The 1502 applied molecular descriptors could provide the best linear models for the selected Alzheimer's data base and the best QSAR model is reported for the considered data sets.
CONCLUSION: The QSAR models developed in this work have a satisfactory predictive ability, and are obtained by selecting the most representative molecular descriptors of the chemical structure, represented through more than a thousand of constitutional, topological, geometrical, quantum-mechanical and electronic descriptor types.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25239202      PMCID: PMC4177578          DOI: 10.1186/s12929-014-0084-0

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  35 in total

1.  Replacement method and enhanced replacement method versus the genetic algorithm approach for the selection of molecular descriptors in QSPR/QSAR theories.

Authors:  Andrew G Mercader; Pablo R Duchowicz; Francisco M Fernández; Eduardo A Castro
Journal:  J Chem Inf Model       Date:  2010-09-27       Impact factor: 4.956

2.  Prediction of drug intestinal absorption by new linear and non-linear QSPR.

Authors:  Alan Talevi; Mohammad Goodarzi; Erlinda V Ortiz; Pablo R Duchowicz; Carolina L Bellera; Guido Pesce; Eduardo A Castro; Luis E Bruno-Blanch
Journal:  Eur J Med Chem       Date:  2010-11-09       Impact factor: 6.514

3.  New QSPR study for the prediction of aqueous solubility of drug-like compounds.

Authors:  Pablo R Duchowicz; Alan Talevi; Luis E Bruno-Blanch; Eduardo A Castro
Journal:  Bioorg Med Chem       Date:  2008-07-29       Impact factor: 3.641

4.  Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids.

Authors:  Maria del Mar Alcalá; Nuria María Vivas; Susana Hospital; Pelayo Camps; Diego Muñoz-Torrero; Albert Badia
Journal:  Neuropharmacology       Date:  2003-05       Impact factor: 5.250

5.  Applications of neural networks in structure-activity relationships of a small number of molecules.

Authors:  I V Tetko; A I Luik; G I Poda
Journal:  J Med Chem       Date:  1993-04-02       Impact factor: 7.446

6.  Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.

Authors:  Pelayo Camps; Xavier Formosa; Carles Galdeano; Diego Muñoz-Torrero; Lorena Ramírez; Elena Gómez; Nicolás Isambert; Rodolfo Lavilla; Albert Badia; M Victòria Clos; Manuela Bartolini; Francesca Mancini; Vincenza Andrisano; Mariana P Arce; M Isabel Rodríguez-Franco; Oscar Huertas; Thomai Dafni; F Javier Luque
Journal:  J Med Chem       Date:  2009-09-10       Impact factor: 7.446

7.  Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.

Authors:  Abdelouahid Samadi; Carolina Valderas; Cristóbal de los Ríos; Agatha Bastida; Mourad Chioua; Laura González-Lafuente; Inés Colmena; Luis Gandía; Alejandro Romero; Laura Del Barrio; María D Martín-de-Saavedra; Manuela G López; Mercedes Villarroya; José Marco-Contelles
Journal:  Bioorg Med Chem       Date:  2010-11-26       Impact factor: 3.641

8.  Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.

Authors:  Pelayo Camps; Xavier Formosa; Carles Galdeano; Tània Gómez; Diego Muñoz-Torrero; Lorena Ramírez; Elisabet Viayna; Elena Gómez; Nicolás Isambert; Rodolfo Lavilla; Albert Badia; M Victòria Clos; Manuela Bartolini; Francesca Mancini; Vincenza Andrisano; Axel Bidon-Chanal; Oscar Huertas; Thomai Dafni; F Javier Luque
Journal:  Chem Biol Interact       Date:  2010-02-16       Impact factor: 5.192

Review 9.  [Therapy of Alzheimer's disease: current status and future development].

Authors:  Reinhold Schmidt; Frauke Neff; Christian Lampl; Thomas Benke; Martina Anditsch; Christian Bancher; Peter Dal-Bianco; Franz Reisecker; Josef Marksteiner; Michael Rainer; Peter Kapeller; Richard Dodel
Journal:  Neuropsychiatr       Date:  2008

Review 10.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

View more
  10 in total

1.  A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs.

Authors:  Sehan Lee; Mace G Barron
Journal:  J Comput Aided Mol Des       Date:  2016-04-07       Impact factor: 3.686

2.  QSAR modeling for predicting mutagenic toxicity of diverse chemicals for regulatory purposes.

Authors:  Nikita Basant; Shikha Gupta
Journal:  Environ Sci Pollut Res Int       Date:  2017-04-24       Impact factor: 4.223

3.  DFT and TDDFT investigation of the Schiff base formed by tacrine and saccharin.

Authors:  Nursel Acar; Cenk Selçuki; Emine Coşkun
Journal:  J Mol Model       Date:  2016-12-29       Impact factor: 1.810

4.  Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg2+ system: molecular dynamics and quantum calculations.

Authors:  Letícia C Assis; Alexandre A de Castro; Ingrid G Prandi; Daiana T Mancini; Juliana O S de Giacoppo; Ranylson M L Savedra; Tamiris M de Assis; Juliano B Carregal; Elaine F F da Cunha; Teodorico Castro Ramalho
Journal:  J Mol Model       Date:  2018-10-02       Impact factor: 1.810

5.  Molecular design of antioxidant lubricating oil additives via QSPR and analysis dynamic simulation method.

Authors:  Usman Abdulfatai; Adamu Uzairu; Sani Uba; Gideon Adamu Shallangwa
Journal:  Heliyon       Date:  2019-11-20

6.  Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase.

Authors:  Ante Miličević; Goran Šinko
Journal:  Saudi Pharm J       Date:  2022-02-08       Impact factor: 4.562

7.  Application of Multivariate Adaptive Regression Splines (MARSplines) for Predicting Antitumor Activity of Anthrapyrazole Derivatives.

Authors:  Marcin Gackowski; Karolina Szewczyk-Golec; Robert Pluskota; Marcin Koba; Katarzyna Mądra-Gackowska; Alina Woźniak
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 5.923

8.  Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease.

Authors:  G Dhamodharan; C Gopi Mohan
Journal:  Mol Divers       Date:  2021-07-29       Impact factor: 2.943

9.  Quantitative structure-activity relationship and molecular docking studies of a series of quinazolinonyl analogues as inhibitors of gamma amino butyric acid aminotransferase.

Authors:  Usman Abdulfatai; Adamu Uzairu; Sani Uba
Journal:  J Adv Res       Date:  2016-11-16       Impact factor: 10.479

10.  QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121).

Authors:  Shola Elijah Adeniji; Sani Uba; Adamu Uzairu
Journal:  J Pathog       Date:  2018-05-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.